Skip to content

Author

A. Madapong

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Rare Adenoviral Vectored Vaccines for Emerging Influenza Threats

Background: Emerging and re-emerging infectious diseases pose a growing global threat, underscoring the need for vaccine platforms enabling rapid deployment and durable, broad protection. Although mRNA and viral vector vaccines transformed pandemic responses, limitations include waning immunity, restricted antigenic br...

Joshua Wiggins, Adthakorn Madapong, Eric A. Weaver · 0 citations
Open access Sep 2026

Systemic and Mucosal Immune Responses From Serotype‐Switched Viral‐Vectored Ebola Vaccines

Ebola virus is a highly virulent pathogen causing severe hemorrhagic fever with 25%–90% mortality. The 2014 outbreak infected over 28,000 people, causing 11,325 deaths. Although there is one FDA‐approved vaccine available for limited use, additional vaccines are needed. We developed adenoviral‐vectored vaccines express...

Joshua Wiggins, A. Madapong, Eric A. Weaver · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.